UK Launch
GW is pleased to announce that Sativex® has been approved in the UK as a prescription medicine for the treatment of spasticity due to multiple sclerosis
On Monday the 21st of June, Dr Geoffrey Guy, chairman of GW Pharmaceuticals, gave an interview to CNBC about Sativex. If you would view this interview online please click on the link below:
